Stock Comparison
ABT vs PEN
Abbott Laboratories and Penumbra Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$163.94B
$12.45B
P/E (TTM)
26.4
73.0
Forward P/E
17.2
62.9
Price/Sales
3.6
8.6
Price/Book
3.2
8.5
EV/EBITDA
16.1
54.5
Dividend Yield
2.62%
—
Profitability
Net Margin
13.90%
11.80%
Operating Margin
13.50%
10.20%
Return on Equity
12.30%
12.70%
Return on Assets
5.59%
6.70%
Growth (YoY)
Revenue Growth
7.80%
15.60%
Earnings Growth
-19.70%
-18.00%
Price & Risk
Beta
0.6
0.7
52-Week High
$135.34
$362.41
52-Week Low
$81.97
$221.26
Analyst Target
$116.54
$364.43
Compare ABT and PEN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.